746 related articles for article (PubMed ID: 28192188)
1. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
2. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
3. Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients.
Mele D; Oliviero B; Mantovani S; Ludovisi S; Lombardi A; Genco F; Gulminetti R; Novati S; Mondelli MU; Varchetta S
Hepatology; 2021 Jan; 73(1):79-90. PubMed ID: 32281670
[TBL] [Abstract][Full Text] [Related]
4. Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.
Conry SJ; Meng Q; Hardy G; Yonkers NL; Sugalski JM; Hirsch A; Davitkov P; Compan A; Falck-Ytter Y; Blanton RE; Rodriguez B; Harding CV; Anthony DD
J Infect Dis; 2012 Apr; 205(7):1131-41. PubMed ID: 22351942
[TBL] [Abstract][Full Text] [Related]
5. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
[TBL] [Abstract][Full Text] [Related]
6. Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56
Long L; Jia M; Fan X; Liang H; Wang J; Zhu L; Xie Z; Shen T
Clin Exp Immunol; 2017 Jul; 189(1):92-102. PubMed ID: 28317093
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection.
Fan X; Zhu L; Liang H; Xie Z; Huang X; Wang S; Shen T
Retrovirology; 2016 Nov; 13(1):76. PubMed ID: 27814766
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection.
Oliviero B; Mele D; Degasperi E; Aghemo A; Cremonesi E; Rumi MG; Tinelli C; Varchetta S; Mantovani S; Colombo M; Mondelli MU
J Hepatol; 2013 Jul; 59(1):38-44. PubMed ID: 23499727
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.
Holder KA; Stapleton SN; Gallant ME; Russell RS; Grant MD
J Immunol; 2013 Sep; 191(6):3308-18. PubMed ID: 23960237
[TBL] [Abstract][Full Text] [Related]
10. Activation of natural killer cells by hepatitis C virus particles in vitro.
Farag MM; Weigand K; Encke J; Momburg F
Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
[TBL] [Abstract][Full Text] [Related]
11. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.
Nattermann J; Feldmann G; Ahlenstiel G; Langhans B; Sauerbruch T; Spengler U
Gut; 2006 Jun; 55(6):869-77. PubMed ID: 16322112
[TBL] [Abstract][Full Text] [Related]
12. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis.
Pollmann J; Götz JJ; Rupp D; Strauss O; Granzin M; Grünvogel O; Mutz P; Kramer C; Lasitschka F; Lohmann V; Björkström NK; Thimme R; Bartenschlager R; Cerwenka A
J Hepatol; 2018 Mar; 68(3):421-430. PubMed ID: 29100993
[TBL] [Abstract][Full Text] [Related]
14. NK cells lacking FcεRIγ are associated with reduced liver damage in chronic hepatitis C virus infection.
Oh JS; Ali AK; Kim S; Corsi DJ; Cooper CL; Lee SH
Eur J Immunol; 2016 Apr; 46(4):1020-9. PubMed ID: 26712042
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection.
Wolter F; Glässner A; Krämer B; Kokordelis P; Finnemann C; Kaczmarek DJ; Goeser F; Lutz P; Nischalke HD; Strassburg CP; Spengler U; Nattermann J
J Hepatol; 2015 Dec; 63(6):1334-44. PubMed ID: 26297916
[TBL] [Abstract][Full Text] [Related]
16. FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32).
Bhatnagar N; Ahmad F; Hong HS; Eberhard J; Lu IN; Ballmaier M; Schmidt RE; Jacobs R; Meyer-Olson D
Eur J Immunol; 2014 Nov; 44(11):3368-79. PubMed ID: 25100508
[TBL] [Abstract][Full Text] [Related]
17. Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells.
Karampatzakis A; Brož P; Rey C; Önfelt B; Cruz De Matos GDS; Rycroft D; Ambrose A; Davis DM
Front Immunol; 2021; 12():641521. PubMed ID: 33796107
[TBL] [Abstract][Full Text] [Related]
18. NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.
Wang SY; Racila E; Taylor RP; Weiner GJ
Blood; 2008 Feb; 111(3):1456-63. PubMed ID: 18024795
[TBL] [Abstract][Full Text] [Related]
19. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI
Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141
[TBL] [Abstract][Full Text] [Related]
20. Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.
Bozzano F; Picciotto A; Costa P; Marras F; Fazio V; Hirsch I; Olive D; Moretta L; De Maria A
Eur J Immunol; 2011 Oct; 41(10):2905-14. PubMed ID: 21695691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
